Please login to the form below

Not currently logged in
Email:
Password:

Polyhedra appoints Steve Hobbs chief business development officer

He joins the group from Apodi

Steve HobbsThe Polyhedra Group has appointed Steve Hobbs as chief business development officer.

He joins the group, which produces secure codes for pharmaceutical packs which patients and healthcare professionals can scan with their smartphone to access resources, from Apodi.

While at Apodi he served as part of its senior management team as director of business and partnership development, having previously founded Australian corporate advisory firm Achieve Capital.

He brings to Polyheda over 30 years international experience in pharmaceuticals and healthcare, gained at firms such as Boehringer Mannheim, Servier Laboratories and Innovex UK, the latter of which saw Hobbs launch launching Innovex in Australia.


15th April 2014

From: Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....